Risk of coronary artery occlusion at second transcatheter aortic valve implantation

Risk of coronary obstruction due to sinus sequestration by redo transcatheter aortic valve implantation in Japanese patients with SAPIEN 3 - Risk of coronary obstruction due to sinus sequestration by redo transcatheter aortic valve implantation in Japanese patients with SAPIEN 3

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050294

Enrollment

300

Registered

2023-02-14

Start date

2023-02-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent TAVI for severe aortic stenosis at Iwate Medical University Hospital and had SAPIEN3 (balloon-expanded transcatheter bioprosthetic valve) implanted. Patients who underwent aortography after implantation of the bioprosthetic valve.

Exclusion criteria

Exclusion criteria: Patients who underwent aortography but could not be adequately evaluated. In addition, patients who were denied opt out.

Design outcomes

Primary

Measure	Time frame
This study aims to clarify the proportion of the risk of sinus of Valsalva sequestration during TAV-in-TAV in Japanese patients.	—

Secondary

Measure	Time frame
To identify preoperative CT and echocardiographic parameters that predict the risk of sinus of Valsalva sequestration.	—

Countries

Japan

Contacts

Public ContactRyo Ninomiya

Iwate Medical University Hospital Department of Internal Medicine, Division of cardiology

rnino0123@gmail.com019-613-7111

Outcome results